` SRDX (Surmodics Inc) vs S&P 500 Comparison - Alpha Spread

SRDX
vs
S&P 500

Over the past 12 months, SRDX has outperformed S&P 500, delivering a return of 12% compared to the S&P 500's 8% growth.

Stocks Performance
SRDX vs S&P 500

Loading
SRDX
S&P 500
Add Stock

Performance Gap
SRDX vs S&P 500

Loading
SRDX
S&P 500
Difference

Performance By Year
SRDX vs S&P 500

Loading
SRDX
S&P 500
Add Stock

Competitors Performance
Surmodics Inc vs Peers

Surmodics Inc
Glance View

Market Cap
420.2m USD
Industry
Health Care

Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. The company is headquartered in Eden Prairie, Minnesota and currently employs 389 full-time employees. The firm operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilization reagents, substrates, surface coatings and antigens.

SRDX Intrinsic Value
18.71 USD
Overvaluation 36%
Intrinsic Value
Price
Back to Top